NCT01824251View on ClinicalTrials.gov

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Interventions
DRUG

NPB-01

Trial Locations (1)

Unknown

Nihon Pharmaceutical Co., Ltd, Osaka

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY